Mark T Muir

Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis

A. Lovett-racke, M. Racke, Mark T Muir, 2005, Expert review of clinical immunology.

Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.

A. Lovett-racke, M. Racke, P. D. Drew, 2006, The Journal of nutrition.

Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis

A. Lovett-racke, M. Racke, Mark T Muir, 2005, Expert review of clinical immunology.